The serum levels of MUC1 or Krebs von den Lungen-6 (KL-6) have been demonstrated to be a useful marker for the diagnosis and monitoring of patients with various interstitial lung diseases including pulmonary fibrosis[72–74]. This evidence concerns the gene MUC1 and pulmonary fibrosis.